<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="https://hdl.handle.net/20.500.11811/618">
<title>Pharmazeutische Biologie</title>
<link>https://hdl.handle.net/20.500.11811/618</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://hdl.handle.net/20.500.11811/13301"/>
</rdf:Seq>
</items>
<dc:date>2026-03-10T21:48:49Z</dc:date>
</channel>
<item rdf:about="https://hdl.handle.net/20.500.11811/13301">
<title>Biosynthesis of the corallorazines, a widespread class of antibiotic cyclic lipodipeptides</title>
<link>https://hdl.handle.net/20.500.11811/13301</link>
<description>Biosynthesis of the corallorazines, a widespread class of antibiotic cyclic lipodipeptides
Dreckmann, Teresa M.; Fritz, Lisa; Kaiser, Christian F.; Bouhired, Sarah M.; Wirtz, Daniel A.; Rausch, Marvin; Müller, Anna; Schneider, Tanja; König, Gabriele M.; Crüsemann, Max
Corallorazines are cyclic lipodipeptide natural products produced by the myxobacterium &lt;em&gt;Corallococcus coralloides&lt;/em&gt; B035. To decipher the basis of corallorazine biosynthesis, the corallorazine nonribosomal peptide synthetase (NRPS) biosynthetic gene cluster &lt;em&gt;crz&lt;/em&gt; was identified and analyzed in detail. Here, we present a model of corallorazine biosynthesis, supported by bioinformatic analyses and &lt;em&gt;in vitro&lt;/em&gt; investigations on the bimodular NRPS synthesizing the corallorazine core. Corallorazine biosynthesis shows several distinct features, such as the presence of a dehydrating condensation domain, and a unique split adenylation domain on two open reading frames. Using an alternative fatty acyl starter unit, the first steps of corallorazine biosynthesis were characterized &lt;em&gt;in vitro&lt;/em&gt;, supporting our biosynthetic model. The dehydrating condensation domain was bioinformatically analyzed in detail and compared to other modifying C domains, revealing unreported specific sequence motives for this domain subfamily. Using global bioinformatics analyses, we show that the &lt;em&gt;crz&lt;/em&gt; gene cluster family is widespread among bacteria and encodes notable chemical diversity. Corallorazine A displays moderate antimicrobial activity against selected Gram-positive and Gram-negative bacteria. Mode of action studies comprising whole cell analysis and &lt;em&gt;in vitro&lt;/em&gt; test systems revealed that corallorazine A inhibits bacterial transcription by targeting the DNA-dependent RNA polymerase.
</description>
<dc:date>2024-08-16T00:00:00Z</dc:date>
</item>
</rdf:RDF>
